News

March 22, 2018

FDA Approves Adcetris, Chemotherapy Combo for Advanced Classical Hodgkin’s Lymphoma

News

The U.S. Food and Drug Administration approved the combination of Seattle Genetics’ Adcetris (brentuximab vedotin) with chemotherapy for the treatment of adults with previously untreated stage 3 or 4 classical Hodgkin’s ... Read more

March 21, 2018March 21, 2018

Women Are Critical to Scientific Discovery, Leukemia and Lymphoma Society Survey Says

News

In a recent survey by the Leukemia and Lymphoma Society (LLS), most Americans recognized that women are critical to scientific discoveries in science, technology, engineering, and math (STEM). LLS highlighted ... Read more

March 20, 2018March 20, 2018

Rich’s RP-323 Shows Activity Against Hodgkin’s Lymphoma in Phase 1 Trial

News

Experimental therapy RP-323 has shown anticancer activity against Hodgkin’s lymphoma in a Phase 1 trial. Its developer, Rich Pharmaceuticals, is now planning to evaluate the therapy in human clinical trials for the disease. ... Read more

March 19, 2018March 19, 2018

MorphosSys Therapy and Revlimid Eliminate Cancer in a Third of DLBCL Patients, Phase 2 Trial Shows

News

A combination of MorphoSys‘ MOR208 and Revlimid (lenalidomide) eliminated cancer cells in almost a third of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a Phase 2 clinical trial shows. Tumor ... Read more

March 15, 2018

Stem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma Patients

News

Results from a recent large-scale study indicate that stem cell transplants should be considered for the treatment of patients with relapsed follicular lymphoma. The study, “Allogeneic Hematopoietic Stem Cell Transplantation ... Read more

March 14, 2018March 14, 2018

G100-Keytruda Combo Shows Higher Response in Follicular Lymphoma Patients in Phase 2 Trial

News

Data from a Phase 2 clinical trial showed that combining Immune Design‘s experimental immunotherapy G100 with fractioned, low-dose radiation and Keytruda (pembrolizumab) leads to higher response rates in follicular lymphoma patients, the company announced. The randomized ... Read more

March 13, 2018March 13, 2018

Fighting Cancer, Accessing Best Treatment Are Why Patients Enroll in Phase 1 Trials, Study Finds

News

The top reasons why patients enroll in Phase 1 clinical trials are “fighting my cancer as much as possible” and “accessing the best treatment,” according to a study presented at ... Read more

March 12, 2018March 12, 2018

Lymphoma, Breast Cancer Patients Have Higher Risk of Heart Failure, Study Shows

News

Breast cancer and lymphoma patients and survivors are 3.6 times more likely to develop heart failure than patients who did not have cancer, a study by researchers at the Mayo ... Read more

March 9, 2018March 9, 2018

Antibiotics May Reduce Chemotherapy’s Effectiveness, Study Suggests

News

Using antibiotics in cancer patients may significantly reduce the effectiveness of chemotherapy agents, which appear to require help from the body’s immune system to function, according to a study by researchers ... Read more

March 8, 2018March 8, 2018

Constellation’s Epigenetic Inhibitors Show Early Signs of Activity in Advanced Lymphoma Patients

News

Two investigative compounds targeting epigenetic DNA modification have shown encouraging preliminary activity in B-cell lymphoma patients, according to results from two Phase 1 trials. The inhibitors, called CPI-1205 and CPI-0610, were found to ... Read more